Target intelligence / Profile preview

Phytohemagglutinin (PHA)

Target
PHA
Molecular classification
Lectin, Plant protein, Glycoprotein
01

Overview

Phytohemagglutinin (**PHA**) is a family of closely related plant lectins found predominantly in red kidney beans (*Phaseolus vulgaris*) and other legumes. It consists mainly of two types of subunits—leukocyte-reactive (L) and erythrocyte-reactive (E)—which combine into tetrameric isolectins with varying biological activities. PHA-L preferentially agglutinates leukocytes and acts as a potent T-cell mitogen by stimulating lymphocyte proliferation; PHA-E primarily aglutinates erythrocytes. The protein binds complex oligosaccharides containing galactose, N-acetyl-glucosamine, and mannose residues on the surface glycoproteins of mammalian cells. In laboratory settings, phytohemaglutinnin serves as an important tool for inducing T-cell division in immunology studies or triggering apoptosis via upregulation of proapoptotic proteins like Bax. When ingested from inadequately cooked beans it can be highly toxic due to its ability to disrupt cellular processes through strong binding interactions with gut epithelial cells[1][2][4][5].

Other names
PHAPhytohaemagglutinin (alternative spelling)Leucoagglutinin (PHA-L)Erythroagglutinin (PHA-E)Mitogenic phytohemagglutininRed kidney bean lectin
02

Mechanism of action

Binds specific carbohydrate structures on cell surfaces leading to agglutination and mitogenic stimulation[2][4].

03

Biological functions

Cell agglutination (causes clumping of blood cells)[4]Induction of mitosis in lymphocytes ("mitogen")[2][10]Apoptosis induction via proapoptotic pathways[5]Modulation of cell membrane transport and permeability[4]
04

Disease associations

Other (used experimentally to induce cell proliferation/apoptosis; causes poisoning if consumed raw)[4][5]
05

Safety considerations

Toxicity when consumed from raw or undercooked beans—can cause severe gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal pain due to its potent hemaglutinating activity[4].

Beyond the preview

Go deeper on Phytohemagglutinin (PHA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phytohemagglutinin (PHA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call